Since some autophagy inducers exert their effects both at p62 synthesis and degradation levels [20], p62 levels were also evaluated in BC cells treated with CPS in combination with the lysosomial inhibitor bafilomycin A (BAF, 25 nM). The gene discussed is SQSTM1; the disease is breast cancer.